Funded Tech Companies

Iterum Therapeutics

Wondering who invested in Iterum Therapeutics? New Leaf Venture Partners, Pivotal bioVenture Partners and Bay City Capital joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Iterum Therapeutics Limited is an Ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/20/2017

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Corey Fishman

        

Chief Financial Officer

Judy Matthews

        

Chief Scientific Officer

Michael Dunne

        

Vice President

Thomas Loughman

        

VP - Bus. Development

John White

        

VP - Operations

Benjamin Pe

        

Company Investors

• New Leaf Venture Partners (Ron Hunt)
• Pivotal bioVenture Partners (Tracy Saxton)
• Bay City Capital
• Frazier Healthcare Partners (Patrick Heron)
• Canaan Partners (Brent Ahrens)
• Domain Associates
• Arix Bioscience (Mark Chin)
• Sofinnova Ventures (James Healy)
• Advent Life Sciences (Shahzad Malik)

Browse more funded tech companies:

Itero Biopharmaceuticals | iTherx Pharmaceuticals

Share this article

About Our Venture Capital Database

The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary